TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
Los Alamos National Laboratory (LANL) is offering a technology licensing opportunity for SurfGraphPro, an advanced AI tool designed to transform complex protein structures into an easy-to-analyze format. This technology significantly speeds up protein analysis, aiding in drug discovery, antibody design, and pathogen detection. Responses are due December 5, 2026.
Technology Overview
SurfGraphPro addresses the challenge of analyzing complex, three-dimensional protein surfaces by converting them into a graph-based representation. This method preserves both the physical shape and biochemical information of surface-exposed amino acids, making it more efficient and flexible for machine learning models. It reduces computational burden and manual feature engineering, allowing for faster, more scalable analysis across various applications.
Key Advantages:
- Simplifies complex protein structures for computational analysis.
- Accelerates protein analysis compared to traditional methods.
- Minimizes manual feature engineering.
- Retains crucial details of protein shape and chemical properties.
- Supports diverse applications including drug discovery, antibody design, and pathogen detection.
- Provides a flexible platform adaptable to various protein-related tasks.
Market Applications
- Pharmaceuticals and Biotechnology: Drug discovery, target screening, protein optimization.
- Biologics and Antibody Development: Antibody engineering, binding analysis, therapeutic design.
- Diagnostics and Infectious Disease: Pathogen detection, biomarker analysis, assay development.
- Agricultural Biotechnology: Protein analysis, crop trait research, bio-based product development.
- Materials and Industrial Science: Protein-mineral interaction studies, polymer compatibility, bio-inspired materials.
- Research Tools and Software: Protein modeling, computational biology, prediction platforms.
Contract & Timeline
- Opportunity Type: Special Notice (Technology Licensing Opportunity)
- Development Status: TRL 3
- Patent Status: US Patent pending
- Set-Aside: None specified (licensing opportunity)
- Published Date: June 5, 2026
- Response Date: December 5, 2026
Additional Notes
This notice is for technology licensing and is not a call for external services for the development of this technology. LANL's licensing program aims to move inventions from researchers to commercial innovations. Patented and patent-pending inventions are available through exclusive and non-exclusive licensing agreements. For specific discussions, contact licensing@lanl.gov.